Adherence To Current Guidelines For Chronic Obstructive Pulmonary Disease (COPD) In Subjects Treated With Combination Of Long-Acting Beta2-Agonist (LABA), Long-Acting Muscarinic Antagonist (LAMA) Or Inhaled Corticosteroids (ics)

被引：0
|
作者：
Asche, C. V.
Leader, S.
Plauschinat, C.
Raparla, S.
Yan, M.
Ye, X.
Young, D.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3115
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Long-Acting β-Agonists (LABA) Combined With Long-Acting Muscarinic Antagonists or LABA Combined With Inhaled Corticosteroids for Patients With Stable COPD
    Horita, Nobuyuki
    Nagashima, Akimichi
    Kaneko, Takeshi
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (13): : 1274 - 1275
  • [22] Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD)
    Ni, Han
    Moe, Soe
    Soe, Zay
    Myint, Kay Thi
    Viswanathan, K. Neelakantan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (12):
  • [23] Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease
    Yuasa, Mizuki
    Tanaka, Yosuke
    Tanaka, Tohru
    Kashiwada, Takeru
    Taniuchi, Namiko
    Saito, Yoshinobu
    Seike, Masahiro
    Hino, Mitsunori
    Gemma, Akihiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [24] ADDITIONAL EFFECT OF INHALED CORTICO STEROID (ICS) ON PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE RECEIVING LONG-ACTING MUSCARINIC ANTAGONIST(LAMA)/ LONG-ACTING β2-AGONIST(LABA) - SINGLE-CENTRE, PROSPECTIVE, REAL-WORLD STUDY
    Tanaka, Yosuke
    Yajima, Chika
    Hino, Mitsunori
    Saitoh, Yozo
    Nishima, Shunichi
    Kosahira, Seiji
    Motohashi, Norihisa
    Gemma, Akihiko
    RESPIROLOGY, 2017, 22 : 178 - 178
  • [25] Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for COPD: A systematic review and meta-analysis
    Horita, Nobuyuki
    Miyazawa, Naoki
    Tomaru, Koji
    Inoue, Miyo
    Kaneko, Takeshi
    RESPIROLOGY, 2015, 20 (08) : 1153 - 1159
  • [26] Combined corticosteroid and long-acting beta2-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
    Javier Nannini, Luis
    Poole, Phillippa
    Milan, Stephen J.
    Kesterton, Annabel
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
  • [27] The Effect of Extra Fine Medium-dose Inhaled Corticosteroid/Long-Acting Beta-2 Agonist/Long-Acting Muscarinic Antagonist (ICS/LABA/LAMA) on Distal Airway Indices Using Functional Respiratory Imaging in Patients With Symptomatic COPD on ICS/LABA
    Lavon, B. R.
    Guasconi, A.
    Georges, G.
    Bates, J. H.
    Galkin, D.
    Muchmore, P.
    Skloot, G. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [28] Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease
    Busch-Petersen, Jakob
    Laine, Dramane I.
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (13) : 1623 - 1634
  • [29] Protective effect of inhaled glucocorticosteroid and long-acting beta2-agonist combination on COPD model
    Titova, Olga
    Kuzubova, Natalya
    Lebedeva, Elena
    Volchkova, Elizaveta
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] Long-acting muscarinic antagonist and long-acting beta 2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery
    Makino, Takashi
    Otsuka, Hajime
    Hata, Yoshinobu
    Koezuka, Satoshi
    Azuma, Yoko
    Isobe, Kazutoshi
    Sugino, Keishi
    Ebihara, Sitorlt
    Homma, Sakae
    Iyoda, Akira
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (05) : 647 - 652
12345